CARDURA

This brand name is authorized in Cyprus, Ecuador, Estonia, Hong Kong, Ireland, Italy, Lithuania, Malta, Mexico, Nigeria, Netherlands, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug CARDURA contains one active pharmaceutical ingredient (API):

1 Doxazosin UNII 86P6PQK0MU - DOXAZOSIN MESYLATE

Doxazosin is a potent and selective post-junctional alpha-1-adrenoceptor antagonist. This action results in a decrease in systemic blood pressure. Read about Doxazosin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CARDURA XL Extended-release tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR
CARDURA Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C02CA04	Doxazosin	C Cardiovascular system → C02 Antihypertensives → C02C Antiadrenergic agents, peripherally acting → C02CA Alpha-adrenoreceptor antagonists
Discover more medicines within C02CA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 29265-06-10, 29690-03-11, 30071-12-11
Country: EE	Ravimiamet	Identifier(s): 1028214, 1028225, 1129799, 1129801
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 13549, 13948, 143440, 14678, 14693, 161462, 180535, 302668, 377176
Country: HK	Department of Health Drug Office	Identifier(s): 31169, 31170, 31171, 45161, 45162
Country: IE	Health Products Regulatory Authority	Identifier(s): 16101, 16122, 16160, 16179, 16202, 16257
Country: IT	Agenzia del Farmaco	Identifier(s): 026821013, 026821025, 039353014, 039353026, 039353038, 039353040, 039462015, 039462027, 039462039, 039462041, 040734016, 040734028, 041749019, 041749021, 043633027, 043633039, 043639018, 044488029, 044488031, 044488043
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1002954, 1002955, 1003517, 1004145, 1008454, 1012028, 1058253, 1072502, 1072503, 1076855, 1083116, 1089478
Country: MT	Medicines Authority	Identifier(s): AA1396/00303, AA1396/00304, AA1438/07601, AA908/17901, AA908/17902, MA1396/00301, MA1396/00302
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 184M2012, 354M89
Country: NG	Registered Drug Product Database	Identifier(s): A4-0272
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 53589, 53597
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100013011, 100013028, 100013034, 100088204, 100088210
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67252001, W67252002
Country: SG	Health Sciences Authority	Identifier(s): 05014P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699532011114, 8699532011121, 8699532015976, 8699532015983, 8699532019141, 8699532019158, 8699532034885, 8699532034892, 8699532035486, 8699532035493
Country: US	FDA, National Drug Code	Identifier(s): 0049-2710, 0049-2720, 0049-2750, 0049-2760, 0049-2770, 0049-2780
Country: ZA	Health Products Regulatory Authority	Identifier(s): 32/7.1/0556, 32/7.1/0557